ACS medicinal chemistry letters
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases.
Ram W Sabnis
Published: 202610.1021/acsmedchemlett.5c00752
Abstract
Open AccessProvided herein are novel imidazopyridazine compounds as IL-17 inhibitors, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.